The Global Biodurable Ophthalmic Drug Delivery System Market Size was estimated at USD 916.91 million in 2023 and is projected to reach USD 1285.99 million by 2029, exhibiting a CAGR of 5.80% during the forecast period.
Report Overview:
Biodurable implants do not break down over time and may be removed or refilled once the treatment is complete.
This report provides a deep insight into the global Biodurable Ophthalmic Drug Delivery System market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biodurable Ophthalmic Drug Delivery System Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biodurable Ophthalmic Drug Delivery System market in any manner.
Global Biodurable Ophthalmic Drug Delivery System Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Glaukos Corp
- Ocular Therapeutix
- Santen Pharmaceutical
- pSivida
- Clearside Biomedical
- Bausch Health
- AptarGroup
- Boehringer Ingelheim
- Allergan
- Re-Vana Therapeutics
- PolyActiva
- Genentech
Market Segmentation (by Type)
- Anterior Drug Delivery Methods
- Posterior Drug Delivery Methods
Market Segmentation (by Application)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Biodurable Ophthalmic Drug Delivery System Market
- Overview of the regional outlook of the Biodurable Ophthalmic Drug Delivery System Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biodurable Ophthalmic Drug Delivery System Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Biodurable Ophthalmic Drug Delivery System
1.2 Key Market Segments
1.2.1 Biodurable Ophthalmic Drug Delivery System Segment by Type
1.2.2 Biodurable Ophthalmic Drug Delivery System Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Biodurable Ophthalmic Drug Delivery System Market Overview
2.1 Global Market Overview
2.1.1 Global Biodurable Ophthalmic Drug Delivery System Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biodurable Ophthalmic Drug Delivery System Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Biodurable Ophthalmic Drug Delivery System Market Competitive Landscape
3.1 Global Biodurable Ophthalmic Drug Delivery System Sales by Manufacturers (2019-2024)
3.2 Global Biodurable Ophthalmic Drug Delivery System Revenue Market Share by Manufacturers (2019-2024)
3.3 Biodurable Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biodurable Ophthalmic Drug Delivery System Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biodurable Ophthalmic Drug Delivery System Sales Sites, Area Served, Product Type
3.6 Biodurable Ophthalmic Drug Delivery System Market Competitive Situation and Trends
3.6.1 Biodurable Ophthalmic Drug Delivery System Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biodurable Ophthalmic Drug Delivery System Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Biodurable Ophthalmic Drug Delivery System Industry Chain Analysis
4.1 Biodurable Ophthalmic Drug Delivery System Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Biodurable Ophthalmic Drug Delivery System Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Biodurable Ophthalmic Drug Delivery System Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Type (2019-2024)
6.3 Global Biodurable Ophthalmic Drug Delivery System Market Size Market Share by Type (2019-2024)
6.4 Global Biodurable Ophthalmic Drug Delivery System Price by Type (2019-2024)
7 Biodurable Ophthalmic Drug Delivery System Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biodurable Ophthalmic Drug Delivery System Market Sales by Application (2019-2024)
7.3 Global Biodurable Ophthalmic Drug Delivery System Market Size (M USD) by Application (2019-2024)
7.4 Global Biodurable Ophthalmic Drug Delivery System Sales Growth Rate by Application (2019-2024)
8 Biodurable Ophthalmic Drug Delivery System Market Segmentation by Region
8.1 Global Biodurable Ophthalmic Drug Delivery System Sales by Region
8.1.1 Global Biodurable Ophthalmic Drug Delivery System Sales by Region
8.1.2 Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Region
8.2 North America
8.2.1 North America Biodurable Ophthalmic Drug Delivery System Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biodurable Ophthalmic Drug Delivery System Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biodurable Ophthalmic Drug Delivery System Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biodurable Ophthalmic Drug Delivery System Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biodurable Ophthalmic Drug Delivery System Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Glaukos Corp
9.1.1 Glaukos Corp Biodurable Ophthalmic Drug Delivery System Basic Information
9.1.2 Glaukos Corp Biodurable Ophthalmic Drug Delivery System Product Overview
9.1.3 Glaukos Corp Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.1.4 Glaukos Corp Business Overview
9.1.5 Glaukos Corp Biodurable Ophthalmic Drug Delivery System SWOT Analysis
9.1.6 Glaukos Corp Recent Developments
9.2 Ocular Therapeutix
9.2.1 Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Basic Information
9.2.2 Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Product Overview
9.2.3 Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.2.4 Ocular Therapeutix Business Overview
9.2.5 Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System SWOT Analysis
9.2.6 Ocular Therapeutix Recent Developments
9.3 Santen Pharmaceutical
9.3.1 Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Basic Information
9.3.2 Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Product Overview
9.3.3 Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.3.4 Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System SWOT Analysis
9.3.5 Santen Pharmaceutical Business Overview
9.3.6 Santen Pharmaceutical Recent Developments
9.4 pSivida
9.4.1 pSivida Biodurable Ophthalmic Drug Delivery System Basic Information
9.4.2 pSivida Biodurable Ophthalmic Drug Delivery System Product Overview
9.4.3 pSivida Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.4.4 pSivida Business Overview
9.4.5 pSivida Recent Developments
9.5 Clearside Biomedical
9.5.1 Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Basic Information
9.5.2 Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Product Overview
9.5.3 Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.5.4 Clearside Biomedical Business Overview
9.5.5 Clearside Biomedical Recent Developments
9.6 Bausch Health
9.6.1 Bausch Health Biodurable Ophthalmic Drug Delivery System Basic Information
9.6.2 Bausch Health Biodurable Ophthalmic Drug Delivery System Product Overview
9.6.3 Bausch Health Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.6.4 Bausch Health Business Overview
9.6.5 Bausch Health Recent Developments
9.7 AptarGroup
9.7.1 AptarGroup Biodurable Ophthalmic Drug Delivery System Basic Information
9.7.2 AptarGroup Biodurable Ophthalmic Drug Delivery System Product Overview
9.7.3 AptarGroup Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.7.4 AptarGroup Business Overview
9.7.5 AptarGroup Recent Developments
9.8 Boehringer Ingelheim
9.8.1 Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Basic Information
9.8.2 Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Product Overview
9.8.3 Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.8.4 Boehringer Ingelheim Business Overview
9.8.5 Boehringer Ingelheim Recent Developments
9.9 Allergan
9.9.1 Allergan Biodurable Ophthalmic Drug Delivery System Basic Information
9.9.2 Allergan Biodurable Ophthalmic Drug Delivery System Product Overview
9.9.3 Allergan Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.9.4 Allergan Business Overview
9.9.5 Allergan Recent Developments
9.10 Re-Vana Therapeutics
9.10.1 Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Basic Information
9.10.2 Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Product Overview
9.10.3 Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.10.4 Re-Vana Therapeutics Business Overview
9.10.5 Re-Vana Therapeutics Recent Developments
9.11 PolyActiva
9.11.1 PolyActiva Biodurable Ophthalmic Drug Delivery System Basic Information
9.11.2 PolyActiva Biodurable Ophthalmic Drug Delivery System Product Overview
9.11.3 PolyActiva Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.11.4 PolyActiva Business Overview
9.11.5 PolyActiva Recent Developments
9.12 Genentech
9.12.1 Genentech Biodurable Ophthalmic Drug Delivery System Basic Information
9.12.2 Genentech Biodurable Ophthalmic Drug Delivery System Product Overview
9.12.3 Genentech Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.12.4 Genentech Business Overview
9.12.5 Genentech Recent Developments
10 Biodurable Ophthalmic Drug Delivery System Market Forecast by Region
10.1 Global Biodurable Ophthalmic Drug Delivery System Market Size Forecast
10.2 Global Biodurable Ophthalmic Drug Delivery System Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biodurable Ophthalmic Drug Delivery System Market Size Forecast by Country
10.2.3 Asia Pacific Biodurable Ophthalmic Drug Delivery System Market Size Forecast by Region
10.2.4 South America Biodurable Ophthalmic Drug Delivery System Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biodurable Ophthalmic Drug Delivery System by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Biodurable Ophthalmic Drug Delivery System Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biodurable Ophthalmic Drug Delivery System by Type (2025-2030)
11.1.2 Global Biodurable Ophthalmic Drug Delivery System Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biodurable Ophthalmic Drug Delivery System by Type (2025-2030)
11.2 Global Biodurable Ophthalmic Drug Delivery System Market Forecast by Application (2025-2030)
11.2.1 Global Biodurable Ophthalmic Drug Delivery System Sales (K Units) Forecast by Application
11.2.2 Global Biodurable Ophthalmic Drug Delivery System Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biodurable Ophthalmic Drug Delivery System Market Size Comparison by Region (M USD)
Table 5. Global Biodurable Ophthalmic Drug Delivery System Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biodurable Ophthalmic Drug Delivery System Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biodurable Ophthalmic Drug Delivery System Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biodurable Ophthalmic Drug Delivery System as of 2022)
Table 10. Global Market Biodurable Ophthalmic Drug Delivery System Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biodurable Ophthalmic Drug Delivery System Sales Sites and Area Served
Table 12. Manufacturers Biodurable Ophthalmic Drug Delivery System Product Type
Table 13. Global Biodurable Ophthalmic Drug Delivery System Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biodurable Ophthalmic Drug Delivery System
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biodurable Ophthalmic Drug Delivery System Market Challenges
Table 22. Global Biodurable Ophthalmic Drug Delivery System Sales by Type (K Units)
Table 23. Global Biodurable Ophthalmic Drug Delivery System Market Size by Type (M USD)
Table 24. Global Biodurable Ophthalmic Drug Delivery System Sales (K Units) by Type (2019-2024)
Table 25. Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Type (2019-2024)
Table 26. Global Biodurable Ophthalmic Drug Delivery System Market Size (M USD) by Type (2019-2024)
Table 27. Global Biodurable Ophthalmic Drug Delivery System Market Size Share by Type (2019-2024)
Table 28. Global Biodurable Ophthalmic Drug Delivery System Price (USD/Unit) by Type (2019-2024)
Table 29. Global Biodurable Ophthalmic Drug Delivery System Sales (K Units) by Application
Table 30. Global Biodurable Ophthalmic Drug Delivery System Market Size by Application
Table 31. Global Biodurable Ophthalmic Drug Delivery System Sales by Application (2019-2024) & (K Units)
Table 32. Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Application (2019-2024)
Table 33. Global Biodurable Ophthalmic Drug Delivery System Sales by Application (2019-2024) & (M USD)
Table 34. Global Biodurable Ophthalmic Drug Delivery System Market Share by Application (2019-2024)
Table 35. Global Biodurable Ophthalmic Drug Delivery System Sales Growth Rate by Application (2019-2024)
Table 36. Global Biodurable Ophthalmic Drug Delivery System Sales by Region (2019-2024) & (K Units)
Table 37. Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Region (2019-2024)
Table 38. North America Biodurable Ophthalmic Drug Delivery System Sales by Country (2019-2024) & (K Units)
Table 39. Europe Biodurable Ophthalmic Drug Delivery System Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Biodurable Ophthalmic Drug Delivery System Sales by Region (2019-2024) & (K Units)
Table 41. South America Biodurable Ophthalmic Drug Delivery System Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Biodurable Ophthalmic Drug Delivery System Sales by Region (2019-2024) & (K Units)
Table 43. Glaukos Corp Biodurable Ophthalmic Drug Delivery System Basic Information
Table 44. Glaukos Corp Biodurable Ophthalmic Drug Delivery System Product Overview
Table 45. Glaukos Corp Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Glaukos Corp Business Overview
Table 47. Glaukos Corp Biodurable Ophthalmic Drug Delivery System SWOT Analysis
Table 48. Glaukos Corp Recent Developments
Table 49. Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Basic Information
Table 50. Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Product Overview
Table 51. Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Ocular Therapeutix Business Overview
Table 53. Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System SWOT Analysis
Table 54. Ocular Therapeutix Recent Developments
Table 55. Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Basic Information
Table 56. Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Product Overview
Table 57. Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System SWOT Analysis
Table 59. Santen Pharmaceutical Business Overview
Table 60. Santen Pharmaceutical Recent Developments
Table 61. pSivida Biodurable Ophthalmic Drug Delivery System Basic Information
Table 62. pSivida Biodurable Ophthalmic Drug Delivery System Product Overview
Table 63. pSivida Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. pSivida Business Overview
Table 65. pSivida Recent Developments
Table 66. Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Basic Information
Table 67. Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Product Overview
Table 68. Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Clearside Biomedical Business Overview
Table 70. Clearside Biomedical Recent Developments
Table 71. Bausch Health Biodurable Ophthalmic Drug Delivery System Basic Information
Table 72. Bausch Health Biodurable Ophthalmic Drug Delivery System Product Overview
Table 73. Bausch Health Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Bausch Health Business Overview
Table 75. Bausch Health Recent Developments
Table 76. AptarGroup Biodurable Ophthalmic Drug Delivery System Basic Information
Table 77. AptarGroup Biodurable Ophthalmic Drug Delivery System Product Overview
Table 78. AptarGroup Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. AptarGroup Business Overview
Table 80. AptarGroup Recent Developments
Table 81. Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Basic Information
Table 82. Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Product Overview
Table 83. Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Boehringer Ingelheim Business Overview
Table 85. Boehringer Ingelheim Recent Developments
Table 86. Allergan Biodurable Ophthalmic Drug Delivery System Basic Information
Table 87. Allergan Biodurable Ophthalmic Drug Delivery System Product Overview
Table 88. Allergan Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Allergan Business Overview
Table 90. Allergan Recent Developments
Table 91. Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Basic Information
Table 92. Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Product Overview
Table 93. Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Re-Vana Therapeutics Business Overview
Table 95. Re-Vana Therapeutics Recent Developments
Table 96. PolyActiva Biodurable Ophthalmic Drug Delivery System Basic Information
Table 97. PolyActiva Biodurable Ophthalmic Drug Delivery System Product Overview
Table 98. PolyActiva Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. PolyActiva Business Overview
Table 100. PolyActiva Recent Developments
Table 101. Genentech Biodurable Ophthalmic Drug Delivery System Basic Information
Table 102. Genentech Biodurable Ophthalmic Drug Delivery System Product Overview
Table 103. Genentech Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Genentech Business Overview
Table 105. Genentech Recent Developments
Table 106. Global Biodurable Ophthalmic Drug Delivery System Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Biodurable Ophthalmic Drug Delivery System Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Biodurable Ophthalmic Drug Delivery System Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Biodurable Ophthalmic Drug Delivery System Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Biodurable Ophthalmic Drug Delivery System Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Biodurable Ophthalmic Drug Delivery System Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Biodurable Ophthalmic Drug Delivery System Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Biodurable Ophthalmic Drug Delivery System Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Biodurable Ophthalmic Drug Delivery System Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Biodurable Ophthalmic Drug Delivery System Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Biodurable Ophthalmic Drug Delivery System Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Biodurable Ophthalmic Drug Delivery System Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Biodurable Ophthalmic Drug Delivery System Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Biodurable Ophthalmic Drug Delivery System Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Biodurable Ophthalmic Drug Delivery System Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Biodurable Ophthalmic Drug Delivery System Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Biodurable Ophthalmic Drug Delivery System Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Biodurable Ophthalmic Drug Delivery System
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biodurable Ophthalmic Drug Delivery System Market Size (M USD), 2019-2030
Figure 5. Global Biodurable Ophthalmic Drug Delivery System Market Size (M USD) (2019-2030)
Figure 6. Global Biodurable Ophthalmic Drug Delivery System Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biodurable Ophthalmic Drug Delivery System Market Size by Country (M USD)
Figure 11. Biodurable Ophthalmic Drug Delivery System Sales Share by Manufacturers in 2023
Figure 12. Global Biodurable Ophthalmic Drug Delivery System Revenue Share by Manufacturers in 2023
Figure 13. Biodurable Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biodurable Ophthalmic Drug Delivery System Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biodurable Ophthalmic Drug Delivery System Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biodurable Ophthalmic Drug Delivery System Market Share by Type
Figure 18. Sales Market Share of Biodurable Ophthalmic Drug Delivery System by Type (2019-2024)
Figure 19. Sales Market Share of Biodurable Ophthalmic Drug Delivery System by Type in 2023
Figure 20. Market Size Share of Biodurable Ophthalmic Drug Delivery System by Type (2019-2024)
Figure 21. Market Size Market Share of Biodurable Ophthalmic Drug Delivery System by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biodurable Ophthalmic Drug Delivery System Market Share by Application
Figure 24. Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Application (2019-2024)
Figure 25. Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Application in 2023
Figure 26. Global Biodurable Ophthalmic Drug Delivery System Market Share by Application (2019-2024)
Figure 27. Global Biodurable Ophthalmic Drug Delivery System Market Share by Application in 2023
Figure 28. Global Biodurable Ophthalmic Drug Delivery System Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Region (2019-2024)
Figure 30. North America Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Biodurable Ophthalmic Drug Delivery System Sales Market Share by Country in 2023
Figure 32. U.S. Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Biodurable Ophthalmic Drug Delivery System Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Biodurable Ophthalmic Drug Delivery System Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Biodurable Ophthalmic Drug Delivery System Sales Market Share by Country in 2023
Figure 37. Germany Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biodurable Ophthalmic Drug Delivery System Sales Market Share by Region in 2023
Figure 44. China Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (K Units)
Figure 50. South America Biodurable Ophthalmic Drug Delivery System Sales Market Share by Country in 2023
Figure 51. Brazil Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biodurable Ophthalmic Drug Delivery System Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Biodurable Ophthalmic Drug Delivery System Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Biodurable Ophthalmic Drug Delivery System Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Biodurable Ophthalmic Drug Delivery System Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biodurable Ophthalmic Drug Delivery System Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biodurable Ophthalmic Drug Delivery System Market Share Forecast by Type (2025-2030)
Figure 65. Global Biodurable Ophthalmic Drug Delivery System Sales Forecast by Application (2025-2030)
Figure 66. Global Biodurable Ophthalmic Drug Delivery System Market Share Forecast by Application (2025-2030)
